Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 139-150

  Wyss Coray, Tony ^a,b   Lin, Carol ^a   Sanan, David A ^a   Mucke, Lennart ^a,b   Masliah, Eliezer ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN TISSUE; MICROVASCULATURE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 0033900999     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64713-X     Document Type: Article

References (69)

1. Cerebral vessels in ageing and Alzheimer's disease
2. Cerebral amyloid angiopathy and Alzheimer's disease: Two entities or one?
3. Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions
4. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease
5. Apolipoprotein E (ε4), and the risk of dementia with stroke: A population-based investigation
6. Brain infarction and the clinical expression of Alzheimer disease: The nun study
7. Vascular changes in senile brains: A micro-angiographic study
8. Brain parenchymal and microvascular amyloid in Alzheimer's disease
9. Cerebral amyloid angiopathy: A critical review
10. Clinical aspects of cerebral amyloid angiopathy
11. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease
12. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly
13. The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage
14. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type
15. Transthyretin amyloidosis: A new mutation associated with dementia
16. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructual study
17. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease
18. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
19. Microanglopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease
20. A morphometric study of the blood-brain barrier in Alzheimer's disease
21. TGF-β in kidney fibrosis: A target for gene therapy
22. Transforming growth factor-β: Vasculogenesis, angiogenesis, and vessel wall integrity
23. Modulation of vascular cell behavior by transforming growth factors β
24. TGF-β1 is an organizer of responses to neurodegeneration
25. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies
26. Altered expression of transforming growth factor-β in Alzheimer's disease
27. Transforming growth factor β in Alzheimer's disease
28. Serum cytokine levels in patients with Alzheimer's disease
29. Amyloidogenic role of cytokine TGF-β in transgenic mice and Alzheimer's disease
30. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1
31. Rodent models of Alzheimer's disease: Rat Aβ infusion approaches to amyloid deposits
32. Effects of transforming growth factor-β (isoforms 1-3) on amyloid-β deposition, inflammation and cell targeting in organotypic hippocampal slice cultures
33. TGFβ potentiates the intracellular aggregation of Aβ in response to apoE: A possible mechanism to form nuclei of Aβ polymerization
34. Alzheimer amyloid angiopathy and transforming growth factor β1
35. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice
36. Spectrum of human immunodeficiency virus-associated neocortical damage
37. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
38. Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels
39. Glucose transporter expression in brain: Relationship to cerebral glucose utilization
40. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study
41. An improved T1/A ribonuclease protection assay
42. Role of endogenously produced interleukin-6 as a second signal in murine thymocyte proliferation induced by multiple cytokines: Regulatory effects of transforming growth factor-β
43. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex
44. Aβ amyloidogenesis: Unique, or variation on a systemic theme?
45. Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type
46. The basement membrane in pathology
47. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor β1 transgenic mice and functional metabolic correlates
48. Alzheimer-type neuropathology in-transgenic mice overexpressing V717F β-amyloid precursor protein
49. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
50. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
51. Transforming growth factor-β in disease: The dark side of tissue repair
52. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
53. Transforming growth factor-β regulates production of proteoglycans by mesangial cells
54. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1
55. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β1
56. Genetic control of the circulating concentration of transforming growth factor type β1
57. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain
58. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells
59. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathyaffected vessels
60. Rapid degeneration of cultured human brain pericytes by amyloid β protein
61. Beta-amyloid-mediated vasoactivity and vascular endothelial damage
62. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells
63. SOD 1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
64. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's Disease: An immunoelectron microscopic study
65. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
66. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells
67. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
68. Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage